Healthcare Finance News August 24, 2023
Project NextGen funding includes $1B for clinical trials, $326M for a new monoclonal antibody and $100M for novel vaccines and therapeutics.
The federal government is releasing $1.4 billion to support clinical trials, coronavirus antibodies and what the Department of Health and Human Services is calling transformative technologies to fight COVID-19.
HHS, through the Administration for Strategic Preparedness and Response, has awarded the more than $1.4 billion through Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA) in partnership with the National Institute of Allergy and Infectious Diseases.
The awards include the following actions:
- $1 billion to four BARDA Clinical Trial partners to support vaccine Phase IIb clinical trial studies: ICON...
Today's Sponsors
Today's Sponsor